Index S&P 500 P/E 15.67 EPS (ttm) 26.05 Insider Own 0.23% Shs Outstand 48.32M Perf Week -3.88%
Market Cap 19.70B Forward P/E 13.99 EPS next Y 29.17 Insider Trans -19.48% Shs Float 48.16M Perf Month -19.29%
Income 1.29B PEG 2.30 EPS next Q 6.31 Inst Own 95.09% Short Float 2.66% Perf Quarter -14.77%
Sales 11.21B P/S 1.76 EPS this Y 2.19% Inst Trans 1.48% Short Ratio 1.54 Perf Half Y 9.38%
Book/sh 47.17 P/B 8.65 EPS next Y 9.67% ROA 20.94% Short Interest 1.28M Perf Year -25.45%
Cash/sh 15.88 P/C 25.69 EPS next 5Y 6.82% ROE 60.91% 52W Range 368.02 - 574.76 Perf YTD -16.72%
Dividend Est. - P/FCF 18.92 EPS past 5Y 18.93% ROI 33.05% 52W High -29.00% Beta 1.35
Dividend TTM - Quick Ratio 0.65 Sales past 5Y 12.33% Gross Margin 39.09% 52W Low 10.88% ATR (14) 13.01
Dividend Ex-Date Mar 16, 2012 Current Ratio 1.70 EPS Y/Y TTM 8.34% Oper. Margin 15.05% RSI (14) 23.74 Volatility 1.95% 2.56%
Employees 56000 Debt/Eq 0.84 Sales Y/Y TTM 9.78% Profit Margin 11.52% Recom 2.13 Target Price 563.06
Option/Short Yes / Yes LT Debt/Eq 0.71 EPS Q/Q 20.91% Payout 0.00% Rel Volume 0.96 Prev Close 419.27
Sales Surprise 0.68% EPS Surprise 7.33% Sales Q/Q 10.15% Earnings Mar 14 AMC Avg Volume 830.38K Price 408.07
SMA20 -10.70% SMA50 -19.59% SMA200 -10.62% Trades
Volume 357,358 Change -2.67%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-19-24 Downgrade Jefferies
Buy → Hold
$585 → $438
Apr-10-24 Reiterated Jefferies
Buy
$610 → $585
Apr-08-24 Upgrade Loop Capital
Hold → Buy
$540
Apr-04-24 Reiterated Oppenheimer
Outperform
$600 → $500
Feb-15-24 Reiterated JP Morgan
Overweight
$535 → $600
Feb-14-24 Downgrade Loop Capital
Buy → Hold
$530
Nov-07-23 Initiated Evercore ISI
Outperform
$460
Jun-13-23 Upgrade Loop Capital
Hold → Buy
$490 → $520
May-19-23 Reiterated Oppenheimer
Outperform
$600 → $575
Mar-28-23 Initiated Canaccord Genuity
Buy
$622
Jan-06-23 Downgrade Wells Fargo
Equal Weight → Underweight
$450 → $400
Dec-12-22 Downgrade Goldman
Buy → Neutral
$511 → $508
Dec-02-22 Reiterated Telsey Advisory Group
Outperform
$510 → $575
Aug-26-22 Initiated William Blair
Outperform
Jun-29-22 Upgrade Raymond James
Outperform → Strong Buy
$475 → $485
May-27-22 Upgrade Jefferies
Hold → Buy
$400 → $475
Dec-03-21 Reiterated UBS
Buy
$455 → $475
Dec-03-21 Reiterated Stifel
Hold
$400 → $435
Dec-03-21 Reiterated Robert W. Baird
Outperform
$460 → $480
Dec-03-21 Reiterated Raymond James
Outperform
$460 → $485
Show Previous Ratings
Today 07:49AM
06:45AM
Apr-23-24 05:45PM
11:06AM
Apr-22-24 06:45PM
05:51AM
Loading…
05:51AM
Apr-19-24 05:21PM
03:38PM
09:26AM
Apr-18-24 05:50PM
08:55AM
03:35AM
Apr-16-24 01:33PM
Apr-12-24 05:50PM
Apr-11-24 09:15AM
04:29PM
Loading…
Apr-10-24 04:29PM
03:53PM
03:30AM
Apr-09-24 05:25PM
09:49AM
Apr-08-24 06:15PM
10:54AM
09:44AM
07:36AM
Apr-07-24 08:00AM
Apr-05-24 10:59AM
Apr-04-24 02:38PM
01:29PM
01:23PM
12:57PM
09:41AM
Loading…
09:41AM
(The Wall Street Journal)
07:30AM
Apr-03-24 07:33PM
07:00PM
05:20PM
(The Wall Street Journal)
04:56PM
04:44PM
04:44PM
04:39PM
04:15PM
04:14PM
(Investor's Business Daily)
04:08PM
04:00PM
03:10PM
02:59PM
(The Wall Street Journal)
02:37PM
02:09PM
02:01PM
01:01PM
12:46PM
12:39PM
12:33PM
12:09PM
11:35AM
11:20AM
10:47AM
12:00AM
Mar-31-24 12:15PM
Mar-28-24 03:24PM
09:42AM
Mar-27-24 01:05AM
Mar-25-24 04:05PM
Mar-23-24 03:57AM
Mar-21-24 07:01PM
07:00PM
07:00PM
Mar-20-24 09:40AM
Mar-19-24 08:30PM
04:48PM
08:39AM
Mar-16-24 05:01PM
Mar-15-24 04:49PM
04:08PM
(Investor's Business Daily)
03:23PM
01:18PM
12:56PM
12:42PM
12:28PM
12:17PM
(Associated Press Finance)
12:01PM
(Investor's Business Daily)
11:01AM
10:44AM
(Investor's Business Daily)
10:08AM
10:04AM
(The Wall Street Journal)
09:05AM
(Thomson Reuters StreetEvents)
09:01AM
07:36AM
07:30AM
06:05AM
04:27AM
Mar-14-24 08:54PM
07:45PM
06:00PM
05:55PM
05:48PM
05:45PM
05:31PM
04:32PM
(Associated Press Finance)
04:19PM
04:05PM
Ulta Beauty, Inc. engages in the retail of beauty products. The company has one reportable segment, which includes retail stores, salon services, and e-commerce. Its products include makeup, skin care, tools and brushes, fragrance, and bath and body. Ulta was founded on January 9, 1990, and is headquartered in Bolingbrook, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Steelman Kecia President and COO Mar 19 '24 Option Exercise 280.38 13,587 3,809,524 31,444 Mar 21 04:46 PM Ryan Anita Jane Chief Human Resources Officer Mar 19 '24 Option Exercise 239.71 2,852 683,662 5,807 Mar 21 04:42 PM Steelman Kecia President and COO Mar 19 '24 Sale 526.39 20,950 11,027,871 10,494 Mar 21 04:46 PM Ryan Anita Jane Chief Human Resources Officer Mar 19 '24 Sale 525.25 3,102 1,629,338 2,705 Mar 21 04:42 PM Halligan Catherine Ann Director Mar 19 '24 Sale 526.26 500 263,131 1,665 Mar 21 04:39 PM Nagler Lorna Director Dec 13 '23 Sale 488.18 500 244,090 6,529 Dec 14 04:57 PM Caro Jodi J GC, Chief Risk & Compl. Ofc. Dec 12 '23 Option Exercise 174.45 1,804 314,708 7,394 Dec 13 04:33 PM Caro Jodi J GC, Chief Risk & Compl. Ofc. Dec 12 '23 Sale 490.02 1,804 883,996 5,590 Dec 13 04:33 PM Halligan Catherine Ann Director Jun 15 '23 Sale 450.00 400 180,000 2,165 Jun 20 04:45 PM MRKONIC GEORGE R JR Director Jun 05 '23 Sale 421.30 393 165,570 2,397 Jun 06 04:35 PM
Index S&P 500 P/E 33.23 EPS (ttm) 3.21 Insider Own 0.73% Shs Outstand 1.73B Perf Week 0.82%
Market Cap 185.26B Forward P/E 20.76 EPS next Y 5.14 Insider Trans -0.97% Shs Float 1.72B Perf Month -2.95%
Income 5.61B PEG 4.26 EPS next Q 1.11 Inst Own 77.09% Short Float 0.84% Perf Quarter -3.62%
Sales 40.33B P/S 4.59 EPS this Y 4.29% Inst Trans 0.27% Short Ratio 2.45 Perf Half Y 11.47%
Book/sh 22.26 P/B 4.80 EPS next Y 11.06% ROA 7.72% Short Interest 14.48M Perf Year -3.29%
Cash/sh 4.19 P/C 25.45 EPS next 5Y 7.80% ROE 15.15% 52W Range 89.67 - 121.64 Perf YTD -3.00%
Dividend Est. 2.12 (1.98%) P/FCF 36.62 EPS past 5Y 19.65% ROI 10.56% 52W High -12.23% Beta 0.75
Dividend TTM 2.12 (1.99%) Quick Ratio 1.16 Sales past 5Y 6.10% Gross Margin 57.58% 52W Low 19.06% ATR (14) 2.12
Dividend Ex-Date Apr 12, 2024 Current Ratio 1.64 EPS Y/Y TTM -16.61% Oper. Margin 16.13% RSI (14) 37.27 Volatility 2.26% 1.73%
Employees 114000 Debt/Eq 0.41 Sales Y/Y TTM -2.84% Profit Margin 13.92% Recom 1.81 Target Price 126.68
Option/Short Yes / Yes LT Debt/Eq 0.38 EPS Q/Q -6.96% Payout 63.81% Rel Volume 0.78 Prev Close 107.59
Sales Surprise 0.82% EPS Surprise 2.62% Sales Q/Q 2.23% Earnings Apr 17 BMO Avg Volume 5.92M Price 106.76
SMA20 -3.00% SMA50 -6.31% SMA200 0.07% Trades
Volume 2,078,208 Change -0.77%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-21-23 Upgrade Wolfe Research
Underperform → Peer Perform
May-30-23 Downgrade Morgan Stanley
Overweight → Equal-Weight
$112
Apr-20-23 Reiterated Wolfe Research
Underperform
$107 → $103
Apr-20-23 Reiterated UBS
Buy
$117 → $130
Apr-20-23 Reiterated Raymond James
Outperform
$116 → $123
Apr-20-23 Reiterated JP Morgan
Overweight
$118 → $122
Apr-20-23 Reiterated Bernstein
Outperform
$132 → $133
Apr-20-23 Reiterated Barclays
Overweight
$125 → $127
Mar-29-23 Initiated UBS
Buy
$117
Oct-26-22 Initiated Mizuho
Neutral
$105
Oct-18-22 Initiated Barclays
Overweight
$118
Oct-12-22 Initiated Jefferies
Hold
$110
Jul-06-22 Initiated Wolfe Research
Underperform
$95
Mar-02-22 Resumed BofA Securities
Buy
$140
Jan-27-22 Reiterated UBS
Buy
$138 → $142
Jan-27-22 Reiterated Raymond James
Outperform
$150 → $143
Jan-27-22 Reiterated Morgan Stanley
Overweight
$157 → $151
Jan-27-22 Reiterated Credit Suisse
Outperform
$138 → $139
Dec-10-21 Initiated RBC Capital Mkts
Outperform
$146
Oct-27-21 Upgrade Atlantic Equities
Neutral → Overweight
$144
Show Previous Ratings
Apr-23-24 03:45PM
Apr-22-24 09:00AM
Apr-19-24 09:44AM
07:53AM
07:37AM
10:55AM
Loading…
Apr-18-24 10:55AM
08:41AM
03:01AM
12:40AM
(Thomson Reuters StreetEvents)
Apr-17-24 04:11PM
(Investor's Business Daily)
04:06PM
(The Wall Street Journal)
02:31PM
(The Wall Street Journal)
01:59PM
01:30PM
12:55PM
(The Wall Street Journal)
11:52AM
Loading…
11:52AM
10:42AM
10:30AM
(Associated Press Finance)
10:19AM
(The Wall Street Journal)
10:13AM
10:02AM
09:54AM
09:30AM
08:51AM
08:40AM
08:00AM
07:58AM
07:52AM
(Investor's Business Daily)
07:46AM
07:36AM
(Associated Press Finance)
07:34AM
Loading…
07:34AM
07:30AM
06:15AM
(The Wall Street Journal)
Apr-16-24 05:04PM
Apr-15-24 11:42AM
Apr-14-24 09:30AM
Apr-13-24 12:18PM
Apr-12-24 09:51AM
09:15AM
08:00AM
(Investor's Business Daily)
Apr-11-24 07:02AM
06:15AM
Apr-09-24 05:50PM
Apr-08-24 01:50PM
10:10AM
09:00AM
Apr-05-24 09:52AM
09:30AM
Apr-03-24 08:00AM
Apr-02-24 04:11PM
11:18AM
09:36AM
09:23AM
09:07AM
09:00AM
Apr-01-24 06:00PM
09:00AM
Mar-31-24 04:34PM
Mar-27-24 04:30PM
12:25PM
Mar-26-24 06:00PM
09:00AM
08:02AM
07:45AM
06:18AM
06:07AM
05:15AM
Mar-25-24 12:58PM
09:15AM
Mar-24-24 10:42AM
Mar-22-24 04:25AM
12:33AM
Mar-21-24 10:25AM
Mar-20-24 05:50PM
08:11AM
08:00AM
Mar-19-24 06:00PM
01:40PM
09:30AM
08:49AM
08:00AM
Mar-18-24 09:50AM
Mar-17-24 08:50AM
Mar-15-24 10:37PM
04:34PM
04:10PM
(Investor's Business Daily)
03:34PM
09:00AM
08:30AM
Mar-14-24 11:02AM
Mar-12-24 05:50PM
08:31AM
06:00AM
Mar-11-24 07:03PM
06:00PM
10:10AM
05:35AM
Mar-07-24 12:27PM
05:00AM
Mar-06-24 04:15PM
(Investor's Business Daily)
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 963 114,116 125,697 Mar 04 07:18 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 853 101,080 184,806 Mar 04 06:39 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 801 94,918 62,968 Mar 04 07:14 PM Earnhardt Lisa D EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 694 82,239 84,314 Mar 04 06:50 PM Moreland Mary K EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 676 80,106 91,260 Mar 04 07:09 PM MCCOY JOHN A. JR. VICE PRESIDENT Mar 01 '24 Sale 118.50 472 55,932 18,760 Mar 04 07:05 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Feb 23 '24 Option Exercise 59.94 12,500 749,250 91,204 Feb 27 06:13 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Feb 23 '24 Sale 120.00 12,500 1,500,000 78,704 Feb 27 06:13 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Jan 29 '24 Option Exercise 50.80 42,500 2,158,950 90,027 Jan 31 05:30 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Jan 29 '24 Sale 112.50 42,500 4,781,250 65,027 Jan 31 05:30 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Dec 14 '23 Option Exercise 44.40 15,000 666,000 80,027 Dec 18 05:36 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Dec 14 '23 Sale 108.00 15,000 1,620,000 65,027 Dec 18 05:36 PM STARKS DANIEL J Director Oct 26 '23 Sale 94.05 50,000 4,702,526 6,725,316 Oct 30 04:58 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Aug 08 '23 Option Exercise 38.40 5,000 192,000 75,427 Aug 10 06:31 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Aug 08 '23 Sale 105.03 10,400 1,092,297 65,027 Aug 10 06:31 PM STARKS DANIEL J Director Jul 27 '23 Sale 113.76 50,000 5,688,189 6,775,316 Jul 28 05:10 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT May 02 '23 Option Exercise 47.00 8,226 386,622 78,653 May 03 07:09 PM STARKS DANIEL J Director May 02 '23 Sale 111.02 50,000 5,551,193 6,825,316 May 02 08:04 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT May 02 '23 Sale 110.56 8,226 909,472 70,427 May 03 07:09 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
